The Effect of Magnesium Sulfate on Motor and Somatosensory Evoked Potentials in Children Undergoing Scoliosis Surgery
| Conditions | Phase | Intervention Type |
|---|---|---|
| Phase 2 |
|
Eligibility
- Ages Eligible for Study
- 12 years to 18 years
- Genders Eligible for Study
- Both
Keywords
pediatrics, Anaesthesia, Scoliosis, and Magnesium
Sponsors
- Other
- The Hospital for Sick Children
Inclusion Criteria
- American Society of Anesthesiologists (ASA) status I or II
- Adolescent children aged 12 to 18 years undergoing surgery for idiopathic scoliosis
Exclusion Criteria
- Magnesium use within the last two weeks, either intravenous or oral supplements
- Patients with known electrolyte imbalances or conduction disorders. (Sodium 143 mmol/L OR Potassium < 3.7 or > 5.0 mmol/L if 12 to 15 yrs; Potassium 4.8 mmol/L if 16 to 18 yrs)
- Renal, cardiac or neuromuscular disorders.(Urea < 2.9 or > 7.1 mmol/L OR Creatinine
>79 µmol/L if < 13 yrs; Creatinine > 98 µmol/L if >= 14 yrs)
Detailed Description
The primary objective of this study is to determine whether magnesium sulfate has a clinically important effect on the amplitude and latency of somatosensory and motor evoked potentials in patients undergoing surgical correction of idiopathic scoliosis.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01148888
Overall Contact Backup
Locations
-
The Hospital for Sick ChildrenToronto, Ontario Canada(Recruiting)
Contact info
Carolyne Pehora416 813 7654x2406carolyne.pehora@sickkids.ca